Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Pharmacokinetics of tenofovir alafenamide, emtricitabine, and dolutegravir in a patient on peritoneal dialysis.

Autor: Massih SA; Division of Clinical Pharmacology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA., Atta MG; Division of Nephrology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA., Thio CL; Division of Infectious Diseases, Department of Medicine, The Johns Hopkins University School of Medicine Baltimore, Baltimore, MD, USA., Tornheim JA; Division of Infectious Diseases, Department of Medicine, The Johns Hopkins University School of Medicine Baltimore, Baltimore, MD, USA., Fuchs EJ; Division of Clinical Pharmacology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA., Bakshi RP; Division of Clinical Pharmacology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA., Marzinke MA; Division of Clinical Pharmacology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, USA., Hendrix CW; Division of Clinical Pharmacology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Division of Infectious Diseases, Department of Medicine, The Johns Hopkins University School of Medicine Baltimore, Baltimore, MD, USA., Weld ED; Division of Clinical Pharmacology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. eweld@jhmi.edu.; Division of Infectious Diseases, Department of Medicine, The Johns Hopkins University School of Medicine Baltimore, Baltimore, MD, USA. eweld@jhmi.edu.

Publikováno v: AIDS research and therapy [AIDS Res Ther] 2024 May 21; Vol. 21 (1), pp. 34. Date of Electronic Publication: 2024 May 21.

Clinically relevant atovaquone-resistant human malaria parasites fail to transmit by mosquito.

Autor: Balta VA; W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21205, USA.; The Johns Hopkins Malaria Research Institute, Baltimore, MD, 21205, USA., Stiffler D; W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21205, USA.; The Johns Hopkins Malaria Research Institute, Baltimore, MD, 21205, USA., Sayeed A; W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21205, USA.; The Johns Hopkins Malaria Research Institute, Baltimore, MD, 21205, USA., Tripathi AK; W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21205, USA.; The Johns Hopkins Malaria Research Institute, Baltimore, MD, 21205, USA., Elahi R; W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21205, USA.; The Johns Hopkins Malaria Research Institute, Baltimore, MD, 21205, USA., Mlambo G; W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21205, USA.; The Johns Hopkins Malaria Research Institute, Baltimore, MD, 21205, USA., Bakshi RP; The Johns Hopkins Malaria Research Institute, Baltimore, MD, 21205, USA.; Division of Clinical Pharmacology, Departments of Medicine and of Pharmacology and Molecular Sciences, The Johns Hopkins University, Baltimore, MD, 21205-2186, USA., Dziedzic AG; W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21205, USA., Jedlicka AE; W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21205, USA., Nenortas E; Division of Clinical Pharmacology, Departments of Medicine and of Pharmacology and Molecular Sciences, The Johns Hopkins University, Baltimore, MD, 21205-2186, USA., Romero-Rodriguez K; Division of Clinical Pharmacology, Departments of Medicine and of Pharmacology and Molecular Sciences, The Johns Hopkins University, Baltimore, MD, 21205-2186, USA., Canonizado MA; Division of Clinical Pharmacology, Departments of Medicine and of Pharmacology and Molecular Sciences, The Johns Hopkins University, Baltimore, MD, 21205-2186, USA., Mann A; W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21205, USA.; The Johns Hopkins Malaria Research Institute, Baltimore, MD, 21205, USA., Owen A; Centre of Excellence in Long-acting Therapeutics (CELT), Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, L69 3BX, UK., Sullivan DJ; W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21205, USA.; The Johns Hopkins Malaria Research Institute, Baltimore, MD, 21205, USA., Prigge ST; W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21205, USA.; The Johns Hopkins Malaria Research Institute, Baltimore, MD, 21205, USA., Sinnis P; W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21205, USA.; The Johns Hopkins Malaria Research Institute, Baltimore, MD, 21205, USA., Shapiro TA; W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21205, USA. tshapiro@jhmi.edu.; The Johns Hopkins Malaria Research Institute, Baltimore, MD, 21205, USA. tshapiro@jhmi.edu.; Division of Clinical Pharmacology, Departments of Medicine and of Pharmacology and Molecular Sciences, The Johns Hopkins University, Baltimore, MD, 21205-2186, USA. tshapiro@jhmi.edu.

Publikováno v: Nature communications [Nat Commun] 2023 Oct 12; Vol. 14 (1), pp. 6415. Date of Electronic Publication: 2023 Oct 12.

Interaction of Depot Medroxyprogesterone Acetate and Tenofovir Disoproxil Fumarate/Emtricitabine on Peripheral Blood Mononuclear Cells and Cervical Tissue Susceptibility to HIV Infection and Pharmacokinetics.

Autor: Coleman JS; Department of Gynecology and Obstetrics, The Johns Hopkins University School of Medicine, Baltimore, MD., Diniz CP; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD., Fuchs EJ; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD., Marzinke MA; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD.; Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD., Aung W; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD., Bakshi RP; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD., Farzadegan H; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD., Bream JH; Department of Molecular Microbiology and Immunology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD., Nilles TL; Department of Molecular Microbiology and Immunology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD., Hudson S; Department of Molecular Microbiology and Immunology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD., Bumpus NN; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD.; Department of Pharmacology and Molecular Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD., Schwartz GJ; Department of Pediatrics, University of Rochester Medical Center, Rochester, NY., Rosenblum MA; Department of Biostatistics, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD; and., Rooney JF; Gilead Sciences, Foster City, CA., Hendrix CW; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD.

Publikováno v: Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2023 Jan 01; Vol. 92 (1), pp. 89-96.

Examining the Safety, Pharmacokinetics, and Pharmacodynamics of a Rectally Administered IQP-0528 Gel for HIV Pre-Exposure Prophylaxis: A First-In-Human Study.

Autor: Al-Khouja A; Division of Clinical Pharmacology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Shieh E; Division of Clinical Pharmacology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Fuchs EJ; Division of Clinical Pharmacology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Marzinke MA; Division of Clinical Pharmacology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Bakshi RP; Division of Clinical Pharmacology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Hummert P; Division of Clinical Pharmacology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Ham AS; ImQuest BioSciences, Frederick, Maryland, USA., Buckheit KW; ImQuest BioSciences, Frederick, Maryland, USA., Breakey J; Division of Clinical Pharmacology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Weld ED; Division of Clinical Pharmacology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Chen H; Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Caffo BS; Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Buckheit RW; ImQuest BioSciences, Frederick, Maryland, USA., Hendrix CW; Division of Clinical Pharmacology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Publikováno v: AIDS research and human retroviruses [AIDS Res Hum Retroviruses] 2021 Jun; Vol. 37 (6), pp. 444-452. Date of Electronic Publication: 2021 Jan 25.